Literature DB >> 10225563

Radiation therapy, cisplatin and hyperthermia in combination in management of patients with carcinomas of the head and neck with N2 or N3 metastatic cervical lymph nodes.

M Serin1, H S Erkal, A Cakmak.   

Abstract

Fifty-three patients with carcinomas of the head and neck with N2 or N3 metastatic cervical lymph nodes were treated with radiation therapy (median, 70 Gy), cisplatin (median, 6 weekly courses) and hyperthermia (median, 6 twice weekly sessions). Local complete response was achieved in 82% and nodal complete response in 85% of patients. Overall survival was 51% and disease-free survival was 54% at 2 years. Toxicity was acceptable. Radiation therapy, cisplatin and hyperthermia in combination prove to be effective and safe in management of these patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225563     DOI: 10.1016/s0167-8140(98)00098-x

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  Inducible promoters for gene therapy of head and neck cancer: an in vitro study.

Authors:  Marianne Schmidt; Tonja Heimberger; Petra Gruensfelder; Gabriele Schler; Florian Hoppe
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-08-12       Impact factor: 2.503

2.  Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up.

Authors:  V Kouloulias; S Triantopoulou; J Vrouvas; K Gennatas; N Ouzounoglou; J Kouvaris; P Karaiskos; P Aggelakis; C Antypas; A Zygogianni; K Papavasiliou; K Platoni; N Kelekis
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-06       Impact factor: 2.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.